Ardent Health Partners Overview
Ardent Health Partners Target Price
See Ardent Health Partners's analyst price targets ($13) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$10.54
Average Target Price
$12.67
20.2% upside
20.2% upside3 analysts in the last 4 months
High: $14 | Low: $11
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-22 | BMO CapitalSean Dodge | $11 | 4.4% upside |  |
| 2026-08-06 | Goldman Sachs | $13 | 23.3% upside | |
| 2026-08-06 | GuggenheimJason Cassorla | $14 | 32.8% upside | |
| 2026-03-09 | RBC CapitalBen Hendrix | $13 | 23.3% upside | |
| 2025-12-18 | UBS | $14 | 32.8% upside | |
| 2025-12-18 | Mizuho SecuritiesAnn Hynes | $12 | 13.9% upside | |
| 2025-11-18 | Mizuho Securities | $13 | 23.3% upside | |
| 2025-11-14 | Leerink PartnersWhit Mayo | $16 | 51.8% upside | |
| 2025-11-14 | Truist Financial | $13 | 23.3% upside | |
| 2025-11-14 | RBC CapitalBen Hendrix | $16 | 51.8% upside | |
| 2025-11-14 | Morgan Stanley | $12 | 13.9% upside | |
| 2025-10-14 | Goldman Sachs | $19 | 80.3% upside | |
| 2025-09-10 | UBS | $17 | 61.3% upside | |
| 2025-03-04 | RBC Capital | $21 | 99.2% upside | |
| 2024-10-10 | KeyBancMatthew Gillmor | $24 | 127.7% upside | |
| 2024-09-19 | StephensScott Fidel | $24 | 127.7% upside | |
| 2024-08-16 | Loop Capital MarketsTimothy Greaves | $21 | 99.2% upside | |
| 2024-08-16 | Truist FinancialDavid MacDonald | $22 | 108.7% upside | |
| 2024-08-12 | Truist FinancialDavid MacDonald | $21 | 99.2% upside | |
| 2024-08-12 | Mizuho SecuritiesAnn Hynes | $20 | 89.8% upside | |
| 2024-08-12 | Morgan StanleyCraig Hettenbach | $27 | 156.2% upside | |